20483 ⎘
Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS
#2COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT
#3PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#4DRUG TARGET FOR INHIBITING TUMOR, USE, AND ORAL DRUG
#5Oral rinse, nasal spray and methods for prevention of COVID-19 by lowering viral load of COVID-19
#6Use of Terpenoids and Salicylates as Anesthetics and Analgesics
#7Biomarker and Druggable Target of Neurodegeneration
#8COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS
#9METHODS AND COMPOSITIONS TO INHIBIT SYMPTOMS ASSOCIATED WITH VEISALGIA
#10THERAPY
#11METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#12Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
#13Electrospun fibers for a local release of an anti-inflammatory drug and a promyelinating drug
#14METHODS FOR TREATING AND PREVENTING NOCICEPTIVE PAIN
#15Platform drug delivery system utilizing crystal engineering and theanine dissolution
#16STABILIZATION OF TRANSTHYRETIN TETRAMERS IN BIOLOGICAL FLUIDS
#17Therapy for transthyretin-associated amyloidosis
#18Compositions and methods of use of phorbolesters
#19COMPOUNDS FOR THE TREATMENT OF DISEASES CAUSED BY OXALATE ACCUMULATION
#20Therapy for transthyretin-associated amyloidosis
#21METHODS FOR DIAGNOSING AND TREATING CACHEXIA
#22Methods and compositions to inhibit symptoms associated with veisalgia
#23TREATMENT OF INFLAMMATORY DISORDERS IN NON-HUMAN MAMMALS
#24METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING CD95- MEDIATED CELL MOTILITY
#25Devices and methods of treating methamphetamine addiction and medical and behavioral consequences of methamphetamine use and of HIV infection
#26Compositions and methods of use of phorbolesters
#27Therapy for transthyretin-associated amyloidosis
#28Methods for treating and preventing nociceptive pain
#29HISTONE MODIFICATION AGENTS FOR CANCER TREATMENT
#30PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#31Compositions and methods of use of phorbol esters
#32Therapy for transthyretin-associated amyloidosis
#33Devices and methods of treating methamphetamine addiction and medical and behavioral consequences of methamphetamine use and of HIV infection
#34Agent for inhibiting odor of pyrazine derivatives
#35SALICYLATES FOR USE IN THE TREATMENT OF CANCER
#36Methods and compositions to inhibit symptoms associated with veisalgia
#37Compositions and methods of use of phorbol esters
#38Anti-infective hydroxy-phenyl-benzoates and methods of use
#39Class II HMG-CoA reductase inhibitors and methods of use
#40Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
#41COSMETIC USE OF NAPTHOIC ACID DERIVATIVES
#42Treatment of inflammatory disorders in non-human mammals
#43INHIBITOR OF COLONISATION OF MUCOSA
#44Anti-infective hydroxy-phenyl-benzoates and methods of use
#45Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription
#46Therapy for transthyretin-associated amyloidosis
#47Method, composition and kit for treating frequent headaches
#48Compositions and methods of use of phorbol esters
#49AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES
#50COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY
#51Anti-infective hydroxy-phenyl-benzoates and methods of use
#52Method for treating a mammal by administration of a compound having the ability to release CO
#53Method of inhibiting the growth of
#54USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#55METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS
#56Therapeutic Agent for Keratoconjunctival Disorder
#57TOPICAL COMPOSITIONS WITH LONG LASTING EFFECT
#58Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
#59Diflunisal for the treatment of cancer
#60Method for treating a mammal by administration of a compound having the ability to release CO
#61Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#62Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
#63Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
#64Methods and reagents for the treatment of metabolic disorders
#65Drug delivery from embolic agents
#66Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light
#67Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
#68Devices and methods of treating methamphetamine addiction and medical and behavioral consequences of methamphetamine use and of HIV infection